ELIZABETH A ADWA
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health YORK, PA NPI 1396224895
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health PA Phathom Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$871.76
- Category: General Payments
- Program years: PY2021–2024
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $507.04 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $507.04 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $151.46 | 2 |
| Sage Therapeutics, Inc. | $119.43 | 1 |
| Gilead Sciences, Inc. | $107.48 | 1 |
| Lilly USA, LLC | $74.41 | 1 |
| Teva Pharmaceuticals USA, Inc. | $30.21 | 1 |
| Neurocrine BioSciences, Inc. | $24.05 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1120403458 | Sage Therapeutics, Inc. | $119.43 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133701876 | Gilead Sciences, Inc. | $107.48 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135616097 | Lilly USA, LLC | $74.41 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150958986 | Neurocrine Biosciences, Inc. | $24.05 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151143848 | Phathom Pharmaceuticals, Inc. | $97.49 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151143850 | Phathom Pharmaceuticals, Inc. | $53.97 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151562652 | Teva Pharmaceuticals USA, Inc. | $30.21 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.